ECOG-ACRIN EA2142

Primary Category:

Treatment Protocols

Disease Category:

Gastrointestinal, Neuroendocrine

Status:

Open

Randomized Phase II Study of Cisplatin and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Carcinomas

NCT#02595424